Trial Profile
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical neuroleptics: A double-blind, randomised, placebo controlled trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 25 May 2011 Additional lead trial centre identified as reported by Australian New Zealand Clinical Trials Registry.
- 25 May 2011 Actual end date (Jun 2006) added as reported by Australian New Zealand Clinical Trials Registry.
- 25 May 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12605000577617).